Physician profile
Allen Gerber
NPI 1316951957
$464,009.41
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131K · 2020: $97K · 2021: $72K · 2022: $89K · 2023: $75K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $54K · Travel and Lodging: $15K · Food and Beverage: $5,154 · Education: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $54,244.00 |
| Travel and Lodging | $15,409.23 |
| Food and Beverage | $5,154.05 |
| Education | $119.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $285,019.17 | 2019-2023 | Mavenclad |
| Biogen, INC. | $61,754.58 | 2019-2022 | |
| Genzyme Corporation | $47,097.45 | 2019-2022 | |
| Celgene Corporation | $27,249.11 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $20,015.63 | 2020-2022 | |
| Genentech USA, INC. | $13,968.97 | 2020-2022 | |
| Horizon Therapeutics Plc | $5,704.85 | 2021-2023 | Uplizna |
| Alexion Pharmaceuticals, INC. | $2,647.59 | 2019-2023 | Soliris |
| Novartis Pharmaceuticals Corporation | $236.42 | 2019-2021 | |
| Genentech, INC. | $141.15 | 2019-2023 | Ocrevus |
| Tg Therapeutics, INC. | $119.76 | 2023 | Briumvi |
| Sanofi-Aventis U.S. LLC | $28.00 | 2019 | |
| Abbvie INC. | $26.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Gerber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.